Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2006-04-04
2006-04-04
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S464000, C424S465000, C424S468000, C424S474000
Reexamination Certificate
active
07022341
ABSTRACT:
The present invention relates to novel oral pharmaceutical compositions comprising as pharmaceutically active compounds a combination of an antihistaminic-effective amount of epinastine or a pharmaceutically acceptable salt thereof and of a decongestant-effective amount of pseudoephedrine or a pharmaceutically acceptable salt thereof and further comprising suitable pharmaceutically acceptable carriers or excipients. The invention further relates to methods for the preparation these compositions and methods of using them in the treatment of allergic diseases and/or disorders.
REFERENCES:
patent: 4996061 (1991-02-01), Webb et al.
patent: 5314697 (1994-05-01), Kwan et al.
patent: 5681582 (1997-10-01), Gilis et al.
patent: 5807579 (1998-09-01), Vilkov et al.
patent: 6039974 (2000-03-01), MacLaren et al.
patent: 6103735 (2000-08-01), Aslanian et al.
patent: 6267986 (2001-07-01), Jain et al.
patent: 2003/0049319 (2003-03-01), Sriwongjanya et al.
patent: 2054752 (1996-12-01), None
patent: 1089471 (1998-05-01), None
patent: 0 311 067 (1989-04-01), None
patent: 0 903 151 (1997-09-01), None
patent: WO 94/09761 (1994-05-01), None
patent: WO 99/09957 (1999-03-01), None
patent: WO 99/32125 (1999-07-01), None
patent: WO 99/32125 (1999-07-01), None
Lipworth, B. J., “Leukotriene-receptor antagonists”; Lancet; 1999; 353; pp. 57-62.
Diamant, Z. et al; “Anti-leukotriene therapy in asthma1”; Netherlands Journal of Medicine 1998; 53, pp. 176-189.
Choi, H-G, et al; “Development of Terfenadine-Pseudoephedrine Double-Layer Tablet Dissolution-Equivalent to Core Tablet”; Drug Development and Industrial Pharmacy; 2000; 26(6); pp. 605-611.
Chemical Abstract: Choi-H-G; “Comparative dissolution test of terfenadine-pseudoephedrine HC1 double-layered and core tablet”; Yakche Hakhoechi; 1997; 27(3) pp. 213-217.
“Zafirlukast”; Martindale—The Complete Drug Reference, 33rd ed., 2002, pp. 785-786.
Leslie Hendeles, “Selecting a Decongestant” Pharmacotherapy 1993; 13(6 PT 2): 129S-134S.
Hernandez, Colin D., “Assesment of the clinical efficacy and safety of epinastine plus pseudoephedrine vs loratadine plus pserdoephedrine in perennial allergic rhinitis” National Library of Medicine, Rev Alerg Mex. Jan.-Feb. 2004; 51(1):23-8.
China Pharmacy, vol. 10, No. 3, 1999, p. 140, with translation.
WPIDS Abstract: WO 9409761 (The Thomson Corp on STN), 1995.
WPIDS Abstract: WO 9409761 (ACS on STN), 1994.
Abelaira Sara
Bianchi Daniel
Cicconi de Vidal Marta
Denker Victor
Fernandez Mabel
Boehringer Ingelheim International GmbH
Bottino Anthony P.
Morris Michael
Page Thurman K.
Sheikh Humera N.
LandOfFree
Pharmaceutical compositions containing epinastine and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions containing epinastine and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions containing epinastine and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3579118